# ARCH CAPITAL GROUP LTD. (ACGLO)

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-03  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/ACGLO/primer

## Business Model

---
source: coverage-next-full
step: "01"
title: Business Overview
ticker: ACGLO
company: Arch Capital Group Ltd.
date: 2026-06-03
---

### Step 01 — Business Overview: Arch Capital Group Ltd. (ACGL / ACGLO)

#### 1. Business Model Summary

Arch Capital Group Ltd. is a Bermuda-based specialty insurance and reinsurance holding company founded in 2001. The company operates a capital-efficient underwriting platform across three segments: **Insurance**, **Reinsurance**, and **Mortgage**. Arch's business model is built on disciplined cycle management — entering and exiting lines aggressively as pricing conditions change — rather than maximizing premium volume. [S1]

The core value proposition: **Arch earns superior risk-adjusted returns on underwriting by being selective in what risk it writes and when, while growing book value per share through a combination of underwriting profit, investment income, and capital return.** The preferred shares (ACGLO, Series F) are a fixed-income instrument offering 5.45% yield backed by the company's AA- credit strength.

#### 2. Value-Chain Layer Map

```
[Capital Providers]
       ↓
[Arch Capital Group (Bermuda HoldCo)] — issues debt ($2.73B senior notes) and equity (ACGL common + ACGLO preferred)
       ↓
[Insurance Underwriting Subsidiaries]          [Mortgage Insurance Subsidiaries]
• Arch Insurance (US, specialty)               • Arch MI (US private MI)
• Arch Reinsurance Ltd. (Bermuda)              • Arch MI Europe (credit risk transfer)
• Arch Insurance Europe (Europe)               • GSE CRT participation
• Arch Lloyd's Syndicate (limited)
       ↓
[Policyholders / Cedents]
• Direct insureds (specialty lines, surety, professional liability)
• Cedents (ceding companies that transfer risk to Arch via reinsurance treaties)
• Mortgage borrowers (via GSE / lender channel)
       ↓
[Claims / Losses]
       ↓
[Investment Portfolio]
• $40.5B invested assets (FY2024)
• 90%+ investment-grade fixed income
• Net investment income $1.5B (FY2024)
       ↓
[Underwriting Profit + Investment Income] → Book Value Growth → Buybacks / Capital Return
```

**Key economic flows:**
1. Premiums collected → invest float → earn net investment income
2. Underwriting discipline → combined ratio <100% → underwriting profit
3. Both streams flow to equity → compound BVPS
4. Excess capital returned via buybacks (no common dividend)

#### 3. Segment Deep Dive

##### Insurance Segment (~44% of FY2024 Net Premiums Written, ~$6.9B)

**Lines:** Specialty lines (aviation, construction, energy), professional liability (D&O, E&O), workers' compensation, surety/fidelity, travel, accident & health, excess casualty, environmental liability.

**Distribution:** Primarily through wholesale and specialty surplus lines brokers in North America; UK, Europe, and emerging markets through insurance subsidiaries.

**Underwriting discipline:** Arch focuses on lines where it has underwriting expertise and pricing advantage; exits lines when conditions deteriorate. The insurance segment runs a ~95% combined ratio (slightly less profitable than reinsurance), but serves as a distribution channel for specialty risk.

**FY2024 Insurance Combined Ratio:** 94.8% (FY2023: 91.7%) [S2]  
**FY2024 Net Premiums Written growth:** ~+17% YoY

##### Reinsurance Segment (~49% of FY2024 Net Premiums Written, ~$7.7B)

**Lines:** Property catastrophe treaty, casualty treaty (GL/auto/umbrella), specialty (marine, aviation, credit), structured reinsurance, proportional and excess-of-loss programs.

**Distribution:** Direct relationships with primary insurance companies (cedents) worldwide; reinsurance brokers (AON, Gallagher, Guy Carpenter).

**Competitive advantage:** Arch's reinsurance culture mirrors a "cat bond plus" approach — willing to accept volatility for superior pricing, but disciplined on accumulations. The reinsurance segment is the highest-ROE business in the portfolio in hard market conditions.

**FY2024 Reinsurance Combined Ratio:** 83.2% (FY2023: 81.4%) — best-in-class [S2]  
**FY2024 Net Premiums Written growth:** ~+25% YoY

##### Mortgage Segment (~7% of FY2024 Net Premiums Written, ~$0.9-1.1B)

**Lines:** Private mortgage insurance (PMI) in the U.S. through Arch MI; mortgage reinsurance; U.S. GSE credit risk transfer (CRT) participation; some international mortgage credit exposure.

**Competitive moat:** Only 6 companies are GSE-approved to write private MI (MGIC, Essent, Arch, Radian, Enact, NMI). Regulatory oligopoly with high barriers to entry; new entrants require GSE eligibility and demonstrated capital strength. [S3]

**Economics:** MI premiums are collected upfront or over policy life; claims paid only on default (currently at historical lows). The segment generates exceptional profitability in benign credit environments.

**FY2024 Mortgage Combined Ratio:** 12.6% — effectively 87+ cents of every dollar is underwriting profit [S2]

#### 4. Revenue Model

**Premium generation:**
- Gross premiums written (GPW) → Ceded to reinsurers → Net premiums written (NPW)
- Arch is a net retainer (retains most risk); cedes selectively to manage accumulations
- NPW earned over policy period → Net premiums earned (NPE)

**Investment income:**
- Float ($40.5B invested assets) generates NII based on duration and yield
- As of FY2024: ~95% fixed-income portfolio; NII = $1.5B (up from $389M in FY2021)
- Rising rate environment since 2022 has materially boosted NII; benefit continues as portfolio rolls to market

**Other income:**
- Net realized gains/losses (volatile; mark-to-market)
- Fee income (minor)

#### 5. Capital Model

Arch is capital-intensive: underwriting requires statutory capital as collateral against loss reserves. Capital sources:
1. **Common equity:** $20.8B (FY2024)
2. **Preferred equity:** Series F ($0.4B approx.) + Series G (smaller)
3. **Senior notes:** $2.73B (fixed rate; no near-term maturities of concern)
4. **Bermuda holdco structure:** Efficient for distributing capital among subsidiaries globally; no US state insurance dept. control at holdco level

**Financial leverage ratio (debt/total capital):** ~12% ($2.73B / ~$23.5B) — conservative for an insurer [S4]

#### 6. Management & Culture

- **CEO (since Oct 2024):** Nicolas Papadopoulo (prior: President, Reinsurance; long Arch veteran)
- **Founder/Former CEO (retired 2024):** Marc Grandisson — architect of Arch's cycle management culture
- **Culture:** No production targets for underwriters; compensation tied to risk-adjusted returns, not premium volume. This is atypical in insurance and is Arch's key behavioral differentiator.
- **Board:** Independent majority; S&P governance noted positively in 2024 AA- upgrade [S5]

#### 7. Thesis Integration

The business model underpins the working thesis from Step 00:  
- **Book value compounding** is the primary value driver (underwriting profit + NII → BVPS growth)  
- **Three-segment diversification** reduces earnings volatility vs. pure-play peers  
- **Culture and discipline** drive superior combined ratios and reserve track record  
- **Preferred (ACGLO)** is a credit story: 5.45% yield backed by AA- balance sheet  

*Thesis updated in tracker: Business model confirmed; cycle management + three-segment model are central pillars.*

#### Source Index

| ID | Source |
|----|--------|
| S1 | Arch Capital Group 10-K FY2024, Business Section (Item 1) |
| S2 | Arch Capital Group 10-K FY2024, MD&A — Segment Results |
| S3 | FHFA PMI eligibility list; industry competitive landscape data |
| S4 | SEC XBRL, balance sheet data, CIK0000947484 |
| S5 | Arch Capital proxy 2024; SEC 8-K governance filings |

## Financial Snapshot

---
source: coverage-next-full
step: "04"
title: Financial Quality & Adversarial Sweep
ticker: ACGLO
company: Arch Capital Group Ltd.
date: 2026-06-03
---

### Step 04 — Financial Quality & Adversarial Research Sweep: Arch Capital Group Ltd. (ACGL / ACGLO)

#### 1. Financial Statement Quality Assessment

##### Statement-of-Operations Quality

**Revenue recognition:** Premiums are earned on a pro-rata basis over the policy period — conservative, well-understood, and auditor-verified. No aggressive accelerations. Net realized gains/losses are volatile but disclosed separately and flagged by management as non-operating. Investment income is straightforward: yield × average invested assets. [S1]

**Loss reserves:** The most significant accounting judgment. Arch carries approximately $18-22B in total loss and LAE reserves (estimate; Arch reports gross reserves in segment detail). Reserve adequacy is:
- Confirmed by annual actuarial certification (per statutory requirements)
- Tested in Note disclosures (prior-year development tables)
- Benchmarked by ratings agencies (AA- from S&P — reflects confidence in reserving)
- Supported by Arch's consistent prior-year favorable reserve development record (no material adverse development in 2020–2024 period per 10-K disclosures) [S2]

**Acquisition costs (DAC):** Deferred over policy period — standard. Amortization ratio of 17.6% (FY2024) is stable and in-line with industry (slightly below average, reflecting Arch's mix of wholesale/excess-of-loss business where acquisition costs are lower). [S1]

**Investment portfolio:** 90%+ investment-grade fixed income. Mark-to-market losses in 2022 were unrealized (AOCI); not recognized through the income statement. Conservative. [S1]

##### Balance Sheet Quality

**Assets:** Dominated by invested assets ($40.5B, 57% of total assets). Reinsurance recoverables ($7-10B estimated — recoveries from ceded reinsurance programs) require credit assessment. Arch's diversified retrocession panel (with highly-rated counterparties) limits credit exposure. No evidence of concentrated counterparty risk in disclosures.

**Liabilities:** Unpaid premiums, losses, and LAE are the primary liabilities. These are estimated; see reserve quality above. Debt at $2.73B senior notes is modest relative to equity ($20.8B). No off-balance-sheet financing structures identified. [S2]

**Equity:** AOCI (accumulated other comprehensive income) includes unrealized gains/losses on fixed income portfolio. 2022 saw AOCI drawdown as rates rose; normalized as rates stabilized in 2023-2024. BVPS excluding AOCI fluctuations still grew consistently.

##### Cash Flow Quality

Operating cash flow: $6.7B (FY2024). This represents 155% of net income — abnormally high due to the premium-collected-in-advance nature of insurance accounting (premiums received before coverage exhausted). This is normal and healthy for an insurer; it confirms the business is not consuming cash to support earnings. [S1]

**Red flags checked:**
- Divergence between net income and operating cash flow: None (positive divergence expected and present)
- Working capital deterioration: N/A for insurance (premiums-in-advance business)
- Goodwill: Modest from historical acquisitions (Watford Holdings 2021, others); no impairment charges
- Off-balance-sheet obligations: None material identified in 10-K disclosures

#### 2. Key Ratio Analysis

##### Profitability

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Loss Ratio (NPE basis) | 51.9% | 50.2% | 55.2% |
| Expense Ratio (est.) | 27-29% | 27-29% | ~27% |
| Combined Ratio (P&C, est.) | ~79-80% | ~77-79% | ~82-84% |
| Operating ROAE | ~14-15% | 21.6% | 18.9% |
| Net Income ROE | ~11.4% | 24.2% | 20.7% |
| NII / Average Investments | ~1.7% | 3.0% | 3.7% |

##### Balance Sheet

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Total Assets ($B) | $48.0 | $58.9 | $70.9 |
| Book Value Per Share ($) | $34.85 | $49.15 | $55.31 (BVPS ex-preferred ~$53.11 management) |
| Financial Leverage (Debt/Capital) | ~17% | ~13% | ~12% |
| Net Debt ($B) | $1.87 | $1.81 | $1.75 |

##### Per-Share Metrics

| Metric | FY2022 | FY2023 | FY2024 |
|--------|--------|--------|--------|
| Diluted EPS ($) | $3.80 | $11.62 | $11.19 |
| BVPS ($) | $32.62 | $46.94 | $53.11 |
| BVPS Growth (%) | -8.7% (AOCI drag) | +43.9% | +13.1% |
| OCF Per Share ($) | ~$10.30 | ~$15.40 | ~$17.72 |

#### 3. Adversarial Research Sweep

##### 3a. Short Seller & Negative Reports

**Findings:** No significant short thesis or activist campaign identified against ACGL. The company has not been a target of prominent short sellers (Citron, Muddy Waters, Hindenburg) as of June 2026. Short interest is modest (estimated <2% of float). [S3]

**Why ACGL is not a typical short target:** Bermuda insurers are transparent (SEC-registered, GAAP reporting); reserve quality is externally audited; no complex corporate structure obfuscating cash flows; management has strong credibility track record.

##### 3b. Legal & Regulatory Investigations

**Findings:** No material class action lawsuits, SEC investigations, or regulatory enforcement actions identified in 10-K risk factor disclosures or press searches as of June 2026. [S2]

**Routine litigation:** As a large insurer, Arch is involved in routine coverage disputes and reinsurance arbitration (industry-standard). These are disclosed in 10-K legal proceedings; none appear material.

**OECD Pillar Two:** The one notable "adversarial" accounting item is the Bermuda tax change. FY2023 net income was boosted by a $1.16B one-time deferred tax benefit from the adoption of Bermuda's OECD Pillar Two 15% minimum tax legislation. This one-time gain inflated FY2023 ROE; normalizing for it, FY2023 operating ROAE was ~21.6%. Management and analysts were transparent about this. [S2]

##### 3c. Governance Red Flags

**CEO transition:** Marc Grandisson (founder-era CEO) retired October 2024. Nicolas Papadopoulo, long-tenured Arch executive (President, Reinsurance), was appointed. This is an internal succession — low risk of cultural or strategic drift. No governance concerns flagged. [S4]

**Compensation structure:** Aligned with underwriting results and ROE; no production volume targets. Executive pay at Arch is considered well-structured by governance analysts. Say-on-pay received 95.3% approval at 2024 AGM. [S4]

**Board independence:** S&P upgrade to AA- in 2024 cited improved governance practices. No related-party transaction concerns identified.

##### 3d. Reserving Risk Assessment

**Key risk:** Insurance reserving is an estimate. Arch's casualty book (both Insurance and Reinsurance segments) is exposed to long-tail social inflation risk — the same risk that caused Everest Group to take a $1B+ reserve charge in FY2024.

**Arch's record:** Arch has NOT taken material adverse reserve development in the 2020–2024 period, unlike Everest Group, Hartford (reserve issues in casualty), or other peers. This reflects:
1. Conservative initial reserving (above-median actuarial selections)
2. Mix toward shorter-tail lines (property) in the reinsurance book
3. Disciplined underwriting with no production pressure

**Risk remains:** Arch is not immune. If social inflation accelerates further in US casualty lines, adverse development is possible. Watching for disclosure of any adverse prior-year development in future 10-Qs. [S2]

##### 3e. Catastrophe Accumulation Risk

**FY2024 events:** Hurricane Helene and Hurricane Milton drove ~$393M pre-tax cat losses. This was within Arch's publicly stated catastrophe risk appetite and did not impair capital significantly.

**California wildfires (Jan 2025):** Arch likely had moderate exposure (consistent with its book composition). No material loss announcement in Q1 2026 results — appears to have been manageable. [S3]

**Risk:** A major capital-market disrupting event (10-year+ return period) could temporarily impair BVPS and require equity issuance. This risk is inherent to the business model and is what creates the pricing cycle that Arch exploits.

#### 4. Financial Quality Verdict

| Dimension | Score | Notes |
|-----------|-------|-------|
| Revenue quality | ★★★★★ | Earned premiums + investment income; predictable |
| Reserving quality | ★★★★☆ | Strong track record; long-tail social inflation risk |
| Balance sheet quality | ★★★★★ | Conservative leverage; investment-grade assets |
| Cash flow quality | ★★★★★ | OCF >> net income; cash-generative model |
| Management integrity | ★★★★★ | No fraud red flags; aligned compensation |
| Accounting quality | ★★★★★ | Standard GAAP; no complex structures |
| **Overall** | **★★★★☆ (4.8/5)** | Best-in-class; only note is inherent cat and reserving tail risk |

*Thesis updated: Financial quality high; no adversarial red flags. Primary risk to thesis is reserving adequacy in casualty lines — monitoring for adverse development.*

#### Source Index

| ID | Source |
|----|--------|
| S1 | SEC EDGAR XBRL Company Facts + StockAnalysis financial data, CIK0000947484 |
| S2 | Arch Capital Group 10-K FY2024, Notes to Financial Statements and MD&A |
| S3 | Consensus.md; press search (MarketBeat, GuruFocus, Benzinga); no short thesis found |
| S4 | Arch Capital proxy 2024; governance_and_compensation.md |

## Recent Catalysts

---
source: coverage-next-full
step: "12"
title: Bull vs. Bear Catalyst Analysis
ticker: ACGLO
company: Arch Capital Group Ltd.
date: 2026-06-03
---

### Step 12 — Bull vs. Bear Catalyst Analysis: Arch Capital Group Ltd. (ACGL / ACGLO)

**Note: This step uses the analyst-debate analytical framework for inferring bull/bear perspectives from filings, press releases, consensus estimates, and news. Earnings transcripts were not loaded — this is the coverage-next-full (filings-and-consensus) path. Management commentary inferences are from 10-K MD&A and press releases only.**

#### 1. Setup: The Debate

ACGL common trades at ~$88.56 (June 2026), approximately **1.48x book value** (~$60 estimated Q1 2026 BVPS). The stock's 52-week range is approximately $75-$120. The core debate is:

**Bull:** ACGL is a best-in-class specialty insurer/reinsurer compounding book value at 15-20% ROAE with durable competitive advantages, trading at a cyclical discount (1.48x P/BV vs. historical 1.7-1.9x). The market is pricing in excessive ROE compression; normalized earnings justify $108-110+ price targets.

**Bear:** The P&C market is softening; property cat rates are declining 5-15%; casualty reserve risk is elevated across the industry; ACGL's FY2026E EPS ($9.58) is well below FY2025 actuals ($11.83), signaling a genuine earnings step-down rather than temporary cyclicality. P/BV of 1.5x is appropriate for a business whose ROE will revert to 14-16%.

#### 2. Bull Case Deep Dive

##### Bull Argument 1: BVPS Compounding is the Story — Not Headline EPS

The bull thesis begins with a simple observation: ACGL's book value per common share has compounded at ~11-13% CAGR for 7 years. If that continues:

| Year | Est. BVPS | P/BV at 1.7x | Implied Stock Price |
|------|-----------|-------------|---------------------|
| 2026E | ~$70 | 1.7x | $119 |
| 2027E | ~$79 | 1.7x | $134 |
| 2028E | ~$89 | 1.7x | $151 |

At the current price of $88.56 and BVPS of ~$60, **the market is pricing Arch at a significant discount to its historical re-rating level.** Even at 1.5x book (which would be conservative given a 17%+ ROAE), the stock is worth ~$105-110 in 12-18 months. [S1]

##### Bull Argument 2: Mortgage Insurance Optionality is Underappreciated

The Mortgage segment generates exceptional returns (12.6% combined ratio — effectively 87+ cents of underwriting profit per dollar of premium). This business:
- Is regulated as an oligopoly (6 providers only)
- Has structural barriers (FHFA approval, capital requirements)
- Benefits from GSE CRT (credit risk transfer) growth as the GSEs expand private market participation
- Is currently in a benign credit environment with low default risk

The market values Arch primarily as a P&C insurer/reinsurer. The mortgage segment's structural value is embedded but not separately valued by most analysts. [S2]

##### Bull Argument 3: Property Cat Soft Market = Temporary; Casualty Hardening = Durable

Property cat market softening (5-15% at 1/1/2025) is a known and priced-in headwind. But:
- Casualty reinsurance is hardening (double-digit rate increases) — Arch can rotate capital from property to casualty
- If a major loss event occurs (2025-2026 hurricane season, earthquake), property pricing will re-harden quickly
- The ACGL cycle management culture means management will pull back from unprofitable property cat rather than compete on price

Bull case: Arch sustains ROAE of 16-18% through the soft market by rotating capital and maintaining discipline. [S2]

##### Bull Argument 4: Analyst Consensus May Be Too Conservative

FY2023 consensus EPS was significantly beaten (actual $11.62 vs. roughly expected $6-8). FY2025 consensus was $8.42 at start of year; actual came in at $11.83. If management's conservative reserving culture translates into consistent positive reserve development and beat cycles, FY2026E consensus of $9.58 may also prove too low. [S3]

##### Bull Argument 5: Director Buying at $94 is a Constructive Signal

Board member Dan Houston purchased 5,300 shares at $94.09 in April 2026. This is an open-market purchase at roughly the current price level. Insiders rarely buy unless they see material undervaluation. At $94, Houston was paying ~1.55x book (estimated Q1 2026 BVPS of ~$60-62). This implies management sees fair value well above current prices. [S4]

#### 3. Bear Case Deep Dive

##### Bear Argument 1: The ROE Cycle is Turning Against Arch

Property cat reinsurance rates are declining. Casualty reinsurance, while hardening, has social inflation risk embedded. FY2026E consensus EPS of $9.58 vs. FY2025 actuals of $11.83 implies a 19% YoY earnings decline. If:
- FY2026 operating ROAE falls to 14-15% (from 18.9%)
- Then fair P/BV at 14-15% ROAE = approximately 1.3-1.5x book

At 1.35x book and ~$70 FY2026E BVPS, the stock is worth ~$94-100 — modest upside from current $88.56. The bear doesn't require a disaster; a gradual ROE compression to 14% makes the stock roughly fairly valued at current prices. [S3]

##### Bear Argument 2: Casualty Reserve Risk is the Next Shoe to Drop

Everest Group (EG) — Arch's closest Bermuda peer — took a ~$1B+ casualty reserve charge in FY2024. The U.S. casualty insurance industry has systematically underestimated social inflation losses. Arch has NOT taken such a charge, which could mean:
- (a) Arch's reserving was adequately conservative — no catch-up needed
- (b) Arch's adverse development is still unrecognized — future charges possible

If Arch takes even a modest casualty reserve charge ($300-500M), that could depress one year's EPS by $0.80-1.30 and shake market confidence in the BVPS compounding narrative. [S1]

##### Bear Argument 3: The Three-Segment Story May Not Re-Rate the Stock

The bull thesis relies partly on a P/BV re-rating from 1.48x to 1.7-1.9x. But if the market views Arch as structurally moving to a lower-ROE environment (due to market softening), the multiple may not expand. The historical 1.7-1.9x P/BV was earned in a period of consistent 16-22% ROAEs. At 14-16% ROAE, 1.5x P/BV may be the appropriate steady-state multiple — leaving little upside from current prices.

##### Bear Argument 4: ILS Continues to Grow

The catastrophe bond and ILS (Insurance-Linked Securities) market has grown to ~$105B. This provides alternative capacity that competes directly with Arch's reinsurance franchise in property cat, creating structural pressure on margins in the most profitable reinsurance lines. While Arch has a strong franchise, the ILS market's growth is a secular headwind to property cat reinsurance pricing. [S2]

#### 4. Bull Case — 3 Bullets

1. **BVPS compounding is undervalued at 1.48x book:** If Arch sustains 16-19% ROAE through the cycle, the stock re-rates to historical 1.7-1.9x P/BV, implying $110-130+ over 12-24 months. Analysts' consensus PT of $108-110 reflects this re-rating.

2. **Mortgage segment is a hidden gem with structural moat:** The regulated PMI oligopoly generates exceptional returns on capital that the market treats as an afterthought; if valued separately at a specialty finance multiple, it adds $10-15/share of value.

3. **Management has consistently beaten consensus and director buying confirms undervaluation:** The pattern of large EPS beats vs. consensus (FY2023, FY2025) combined with director Houston's April 2026 purchase at $94 signals that insiders see material undervaluation.

#### 5. Bear Case — 3 Bullets

1. **ROE compression to 14-15% in the soft cycle makes the stock fairly valued, not cheap:** With FY2026E EPS of $9.58 and a P/E of ~10x, the stock at $88-95 offers limited upside without a re-rating catalyst.

2. **Casualty reserve risk remains a threat:** Arch has avoided an Everest-style reserve charge so far, but U.S. casualty social inflation is systemic; a $300-500M adverse development charge would undermine the BVPS growth narrative for one year and reset consensus lower.

3. **Property cat softening is secular, not cyclical:** ILS market growth is a structural tailwind for cedents (cheaper reinsurance) and headwind for traditional reinsurers; Arch's most profitable segment (Reinsurance, 83.2% combined ratio) faces margin compression that may not fully reverse even in the next hard market.

*Thesis updated: Bull case is moderately compelling at 1.48x P/BV if ROAE is sustained at 16%+. Bear case is credible if ROE compresses to 14% and casualty reserves deteriorate. Current price represents a moderate risk/reward with upside contingent on ROAE sustainability.*

#### Source Index

| ID | Source |
|----|--------|
| S1 | Arch Capital 10-K FY2024; competitive landscape (Everest Group comparison) |
| S2 | Gallagher Re market overview; industry competitive landscape; investor presentation |
| S3 | Consensus estimates (MarketBeat, TipRanks, Cantor Fitzgerald); StockAnalysis |
| S4 | Insider transactions (Form 4); insider_transactions.md |

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/acglo
- Full research API: GET /api/v1/research/ACGLO/memo
- Coverage universe: /stocks